Puxitatug Samrotecan

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Puxitatug Samrotecan
Treatment and conditionWhere it standsTrials
Puxitatug Samrotecan for endometrial neoplasmsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Puxitatug Samrotecan for neoplasm metastasisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1